Related Experiment Video
Updated: Jun 18, 2026
12:43
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
Published on: February 21, 2011
Speech and Swallowing in Parkinson's Disease
1Department of Communicative Disorders and Sciences, University at Buffalo, Buffalo, NY.
Topics in Geriatric Rehabilitation
|December 1, 2009
Summary
Parkinson's disease (PD) frequently causes dysarthria and dysphagia, impacting speech and swallowing. Treatments focusing on prosody and communication strategies can improve intelligibility, while early dysphagia management is crucial for health and quality of life.
Area of Science:
- Neurology
- Speech-Language Pathology
Background:
- Parkinson's disease (PD) commonly presents with dysarthria and dysphagia.
- Reduced speech intelligibility in PD-related dysarthria stems from articulatory and phonatory impairments.
- Dysphagia in PD poses significant health risks, including aspiration pneumonia, malnutrition, and dehydration.
Purpose of the Study:
- To review the impact of dysarthria and dysphagia in Parkinson's disease.
- To highlight effective treatment strategies for speech and swallowing deficits in PD.
Main Methods:
- Literature review of studies on Parkinson's disease, dysarthria, and dysphagia.
- Analysis of treatment approaches for speech intelligibility and swallowing function.
Main Results:
- Prosody-based treatments show promise for improving speech intelligibility in PD.
- Communication strategies enhance listener understanding.
- Early identification and management of swallowing abnormalities are critical for patient outcomes.
Conclusions:
- Dysarthria and dysphagia are significant challenges in Parkinson's disease.
- A combination of speech therapies and communication strategies can improve outcomes for dysarthria.
- Interventions for dysphagia, including feeding modifications and therapeutic techniques, are essential for managing health risks and improving quality of life in PD patients.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.